Advanced search
Publication Cover
Accountability in Research
Ethics, Integrity and Policy
Volume 20, 2013 - Issue 4
Submit an article Journal homepage
889
Views
14
CrossRef citations to date
0
Altmetric
Original Articles

When Everyone Is an Orphan: Against Adopting a U.S.-Styled Orphan Drug Policy in Canada

Matthew Herder B.Sc. (Hons.) LL.B. LL.M. J.S.M. Health Law Institute, Faculties of Medicine and Law, Dalhousie University, Halifax, Nova Scotia, CanadaCorrespondence[email protected]
Pages 227-269 | Published online: 27 Jun 2013

Citations (14)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Jan Maci & Petra Marešová. (2022) Critical Factors and Economic Methods for Regulatory Impact Assessment in the Medical Device Industry. Risk Management and Healthcare Policy 15, pages 71-91.
Read now

Articles from other publishers (13)

Adrián Alonso Ruiz, Kaitlin Large, Suerie Moon & Marcela Vieira. (2023) Pharmaceutical policy and innovation for rare diseases: A narrative review. F1000Research 12, pages 211.
Crossref
Adrián Alonso Ruiz, Kaitlin Large, Suerie Moon & Marcela Vieira. (2023) Pharmaceutical policy and innovation for rare diseases: A narrative review. F1000Research 12, pages 211.
Crossref
Haytham Alewaidat, Ziad Bataineh, Mohammad Bani-Ahmad, Manar Alali & Ali Almakhadmeh. (2023) Investigation of the diagnostic importance and accuracy of CT in the chest compared to the RT-PCR test for suspected COVID-19 patients in Jordan. F1000Research 12, pages 741.
Crossref
Abhimanyu Sud, Meghan McGee, Barbara Mintzes & Matthew Herder. (2022) Permissive regulation: A critical review of the regulatory history of buprenorphine formulations in Canada. International Journal of Drug Policy 105, pages 103749.
Crossref
Bettina M. Zimmermann, Johanna Eichinger & Matthias R. Baumgartner. (2021) A systematic review of moral reasons on orphan drug reimbursement. Orphanet Journal of Rare Diseases 16:1.
Crossref
Olga A. Belousova, Aard J. Groen & Aniek M. Ouendag. (2020) Opportunities and barriers for innovation and entrepreneurship in orphan drug development. Technological Forecasting and Social Change 161, pages 120333.
Crossref
Kerstin Noëlle Vokinger & Aaron S Kesselheim. (2019) Application of orphan drug designation to cancer treatments (2008–2017): a comprehensive and comparative analysis of the USA and EU. BMJ Open 9:10, pages e028634.
Crossref
Irina Degtiar. (2017) A review of international coverage and pricing strategies for personalized medicine and orphan drugs. Health Policy 121:12, pages 1240-1248.
Crossref
Aaron S. Kesselheim, Carolyn L. Treasure & Steven Joffe. (2017) Biomarker-Defined Subsets of Common Diseases: Policy and Economic Implications of Orphan Drug Act Coverage. PLOS Medicine 14:1, pages e1002190.
Crossref
Monika Wagner, Hanane Khoury, Jacob Willet, Donna Rindress & Mireille Goetghebeur. (2015) Can the EVIDEM Framework Tackle Issues Raised by Evaluating Treatments for Rare Diseases: Analysis of Issues and Policies, and Context-Specific Adaptation. PharmacoEconomics 34:3, pages 285-301.
Crossref
Y. Schuller, C. E. M. Hollak & M. Biegstraaten. (2015) The quality of economic evaluations of ultra-orphan drugs in Europe – a systematic review. Orphanet Journal of Rare Diseases 10:1.
Crossref
Shannon Gibson, Hamid R. Raziee & Trudo Lemmens. (2015) Why the Shift? Taking a Closer Look at the Growing Interest in Niche Markets and Personalized Medicine. World Medical & Health Policy 7:1, pages 3-27.
Crossref
Matthew Herder. (2016) House of Commonss Standing Committee on Health: Development of a National Pharmacare Program. SSRN Electronic Journal.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.